#ctos2021 результаты поиска
#CTOS2021 thx @alegronchi 🇮🇹 #surgicaloncology is more than about tecniques, is a lot about decisions! Nina Axelrad Award well deserved @ctosociety @IstTumori @TARPSWG @SICOBoard @DCalleMD @radaste @sandro_pasquali
Very interesting data on larotrectinib discontinuation w/o progression on NTRK+ childhood sarcoma 👉 no pt with surgical resection and pCR recurred 👉 most pts with nonsurgical CR also did not progress 👉 efficacy on rechallenge was high #CTOS2021
#CTOS2021 Final results of AMPECT trial nab-sirolimus in PEComa - a trial met its primary endpoint with an ORR of 39% and produced long-term durable responses @ctosociety
#CTOS2021 - In an era of increasing use of nomograms, great presentation in reference to the need to UPDATE nomograms. In this analysis, recalibration of the sarculator for retroperitoneal #sarcoma led to better capacity to predict outcomes.
#CTOS2021 is a month away! Though not mtg physically in #Vancouver, Looking forward to exciting #longweekend filled w/ latest updates in #sarcomas. Join us at #Session8: #Oncology & #ClinicalTrials which I have the pleasure in co-chairing! #sleepless #virtualjetlag #CUHKSarcoma
#ctos2021 day1 is off. Much stuff! Now 🇮🇹 delegates enjoying social program. Missing in person meetings! Ps- boost #vaccination addicted! @GiacomoGBaldi @alegronchi @SilviaStacchia @ManuPalmerini @DCalleMD @sandro_pasquali @radaste @apdeitos @sbamarta
We are delighted and proud having the #CTOS2021 Herman Suit award winner Prof. Judith Bovée, pathologist from @LUMC_Leiden (also) live here in our midst. As always, giving an outstanding lecture! #sarcoma
Great RPS session @CTOS #CTOS2021 congrats to speakers 👏🏼 @Korosh_Khalili @FioreDoc @DCalleMD @TirottaFabio #deannaNg and thoughtful moderators. Making progress, refining care and new hypothesis!!!
pembrolizumab and eribulin in soft tissue #sarcoma presented by Suzanne George 🌟LPS - 12-week PFS rate 69% - mPFS of 27.4 wks 🌟other sarcoma - 12-week PFS rate 56% (UPS 63%) 📢interesting combo for further studies @ctosociety #CTOS2021 @OncoAlert
#CTOS2021 comes to an end...great final talk by the @ctosociety president Dr. Haas on the past, present and future of sarcoma research
Bravissimo @alegronchi in his Nina Axelrad Lecture in #CTOS2021!!! A wonderful walkthrough of an amazing career. Your contribution to sarcoma care is exceptional. From @GrupoGeis we are honored of our friendship and continuous collaboration to improve sarcoma patient’s outcome
Dr. Ashleigh Guadagnolo @ashleighg @ctosociety #CTOS2021 prelim results of single arm trial 3wk hypofrx preop RT for truncal/extr. STS 42.75 Gy in 15: major wound rates & early LC comparable to historical. Look forward to longer FU from this potentially practice changing trial
Great discussion in the GIST session. Congrats and thanks to Dr Martin Broto for representing @GrupoGeis in this #CTOS2021. Lessons of the day: 1.Placebo arms in metastatic GIST trials should be discouraged; 2. Correct molecular analysis is essential #GIST #Genotyping
#CTOS2021 Are microscopic margins affecting patients outcomes in retroperitoneal #sarcoma? R1 was independently associated with higher Local recurrence rate @TARPSWG @DCalleMD @Dirk_Strauss @SBonvalot @chandrajitraut @WinanvanHoudt @GladdyLab @FioreDoc @alegronchi @OncoAlert
Top Influencers of #CTOS2021 Honoured to be among these #sarcoma twitter experts👉 @ctosociety @JTrentMDPhD @pawel_sobczuk @VivekSubbiah @OncoAlert @GrupoGeis @PestanaRC @FioreDoc @sarcomapatients @bvantine1 by @symplur
Joining #CTOS2021 across many continents (🤞🏻 wifi allows). Not a bad way to spend what is usually a long trip to 🇮🇪 #sarcoma #VirtualConferenceLife
#CTOS2021 was amazing, but I hope for the 2022 meeting we can tour in person @ctosociety 🗓 Next year with the addition of zebra hunter @jtmoyers 🎶 Our hits are as ultra rare as some sarcomas @VivekSubbiah @Jason_MDA @RGroisberg
Today #CTOS2020 ended, excellent meeting and excellent speakers, see you at #CTOS2021 @ctosociety @TARPSWG @SelnetH2020 @alegronchi @FioreDoc @JTrentMDPhD @tomassoule @haydeecaros
I thought this was interesting, considering @Korosh_Khalili's presentation at #CTOS2021 on abdominal #leiomyosarcoma arising from veins that drain sex hormone producing organs. #sarcoma
Leiomyosarcoma arising from the ovarian vein as a gynecologic malignancy: Two case reports and a review of the literature dlvr.it/STTZKM #sarcoma #leiomyosarcoma
Excited to share my recently published paper in Cancer Epidemiology investigating the #epidemiology of desmoid tumors in Denmark, previously presented at #CTOS2021 📜#raredisease Available free for 50 days ⏲️ authors.elsevier.com/c/1eWDQ6gzKuME…
INTERIM SAFETY AND EFFICACY RESULTS FROM A PHASE 1/2 STUDY OF BA3011, A CAB-AXL-ADC, IN PATIENTS WITH ADVANCED SARCOMA OR OTHER SOLID TUMORS #CTOS2021 cdmcd.co/93yxXQ
Tired of Zoom🖥️? Eager to network? Weary of cold winters🥶? Don't miss this F2F #Sarcoma event. "The Best of CTOS" will highlight #CTOS2021 @ctosociety & more! Keynote speakers Dr. @ashleighg & Bob Maki @DrMeenaBedi & I look forward to seeing you IRL. web.cvent.com/event/10346ae9…
Excited to share outcomes from the MoST study at #CTOS2021 @ProfDMThomas @RareCancers @GarvanInstitute @PeterMacCC @NSWHealth @MedResearchNSW
💉 Systemic therapy: prospective data on bevacizumab, sorafenib, and trametinib; moreover, prospective study on eribulin #CTOS2021 included EHE (but only 4 pts included)
We are looking forward to @IntensityInc’s presentations at both #SITC21 and #CTOS2021, which highlight promising efficacy and survival data of INT230-6 (PORT-1). Learn more about the data presentations here: bit.ly/3kDeMNt
🧵1. How terrible to be pregnant & get diagnosed with #sarcoma! In a poster at #CTOS2021, researchers looked at 12 cases in which pregnant women got chemo (an anthracycline such as doxorubicin and/or ifosfamide).
🧵About 1,000 physicians, scientists & other health-care professionals registered for #CTOS2021, the international #sarcoma conference that just ended. It was virtual but had been planned for Vancouver.
It was an honour to present our work about #oncoplastic #surgery during an inspiring session at #CTOS2021 @ctosociety 📚Thanks @SBonvalot for the mentorship ⚖️Thanks @CrisyRoland for leading the session 💡Thanks @WinanvanHoudt for the interesting comments
#CTOS2021 was amazing, but I hope for the 2022 meeting we can tour in person @ctosociety 🗓 Next year with the addition of zebra hunter @jtmoyers 🎶 Our hits are as ultra rare as some sarcomas @VivekSubbiah @Jason_MDA @RGroisberg
You all did a wonderful job. #CTOS2021 was a great success. Thank you!
TK216 efficacy could be tied to length of infusion and so trial is now testing 28-day (from 14-day) infusions. Totally agree that we must discover why the 10% with an objective response (2 CRs!) had them! #CTOS2021
A bit disappointing update on TK216 (ETS inhibitor) ± vincristine in #Ewing #sarcoma 🔸ORR 9.7%, DCR 45.2% 🔸mPFS 1.9 m, mOS 10.3 m correlative studies to understand who responds are needed @RavinRatan #CTOS2021 @ctosociety @EwingStudy @EwingsSarcomaRT
A bonus of this years #CTOS2021 is finding some excellent new #MedTwitter #sarcoma friends. As I catch up on the conference, here are some highlights from others, including this abstract from Dr. Steve DuBois @DFBC_PedCare
Very interesting data on larotrectinib discontinuation w/o progression on NTRK+ childhood sarcoma 👉 no pt with surgical resection and pCR recurred 👉 most pts with nonsurgical CR also did not progress 👉 efficacy on rechallenge was high #CTOS2021
Thank you Suzie. Looking forward to building on the momentum of #CTOS2021. What an amazing meeting. We have a remarkable international community!
Couldn’t agree more! #patientsinvolved #sarcoma #CTOS2021 #collaboration
Patient-centered care cannot be advanced without patient input in clinical research #CTOS2021 @sarcomapatients @SelnetH2020
Top Influencers of #CTOS2021 👉 @JTrentMDPhD @ctosociety @pawel_sobczuk @OncoAlert @VivekSubbiah @PestanaRC hcsm.io/3qmqP5r via @symplur
#CTOS2021 thx @alegronchi 🇮🇹 #surgicaloncology is more than about tecniques, is a lot about decisions! Nina Axelrad Award well deserved @ctosociety @IstTumori @TARPSWG @SICOBoard @DCalleMD @radaste @sandro_pasquali
#ctos2021 day1 is off. Much stuff! Now 🇮🇹 delegates enjoying social program. Missing in person meetings! Ps- boost #vaccination addicted! @GiacomoGBaldi @alegronchi @SilviaStacchia @ManuPalmerini @DCalleMD @sandro_pasquali @radaste @apdeitos @sbamarta
@RussellGWitt and Raul Valenzuela @MDAndersonNews discussing diagnostic and therapeutic techniques in #sarcoma #CTOS2021 #oncsurgery @emilykeungMD
One of the most inspiring surgeons, committed researcher and also such a good friend! Terrific Nina Axelrad lecture by @alegronchi at #CTOS2021. So much to learn from the #sarcoma community! @SilviaStacchia
pembrolizumab and eribulin in soft tissue #sarcoma presented by Suzanne George 🌟LPS - 12-week PFS rate 69% - mPFS of 27.4 wks 🌟other sarcoma - 12-week PFS rate 56% (UPS 63%) 📢interesting combo for further studies @ctosociety #CTOS2021 @OncoAlert
Top Influencers of #CTOS2021 Honoured to be among these #sarcoma twitter experts👉 @ctosociety @JTrentMDPhD @pawel_sobczuk @VivekSubbiah @OncoAlert @GrupoGeis @PestanaRC @FioreDoc @sarcomapatients @bvantine1 by @symplur
Great discussion in the GIST session. Congrats and thanks to Dr Martin Broto for representing @GrupoGeis in this #CTOS2021. Lessons of the day: 1.Placebo arms in metastatic GIST trials should be discouraged; 2. Correct molecular analysis is essential #GIST #Genotyping
Never stop learning because @ctosociety never stops teaching! I'm certainly looking forward to #ctos2021 in #Vancouver.
@FioreDoc presenting significant improvement in treatment outcomes in retroperitoneal #sarcoma treated in @IstTumori Beautiful example how the efforts of @TARPSWG and @alegronchi help patients 👏 #CTOS2021 @ctosociety
#CTOS2021 Final results of AMPECT trial nab-sirolimus in PEComa - a trial met its primary endpoint with an ORR of 39% and produced long-term durable responses @ctosociety
Today #CTOS2020 ended, excellent meeting and excellent speakers, see you at #CTOS2021 @ctosociety @TARPSWG @SelnetH2020 @alegronchi @FioreDoc @JTrentMDPhD @tomassoule @haydeecaros
Great RPS session @CTOS #CTOS2021 congrats to speakers 👏🏼 @Korosh_Khalili @FioreDoc @DCalleMD @TirottaFabio #deannaNg and thoughtful moderators. Making progress, refining care and new hypothesis!!!
@jtmoyers and his "STRIPES ON A HERD OF ZEBRAS" Enrollement on matched trials showed a trend towards higher OS compared to unmatched patients! ‼️Genetic testing is useful in #sarcoma ... but when and for whom it should be offered (especially with limited resources)⁉️ #CTOS2021
Bravissimo @alegronchi in his Nina Axelrad Lecture in #CTOS2021!!! A wonderful walkthrough of an amazing career. Your contribution to sarcoma care is exceptional. From @GrupoGeis we are honored of our friendship and continuous collaboration to improve sarcoma patient’s outcome
#CIOs #CTO #CTOS2021 presenting an #innovative #vault to store all your credentials, without any #password, single use token or #biometrics @WIRED @thenextweb @arstechnica @guardiantech @ZDNet
New to the Virtual Meeting #CTOS2021 Live Poster Discussions. Discuss your favorite ❤️ posters with the authors! Taking place now! #ctos #sarcoma #postersession
Something went wrong.
Something went wrong.
United States Trends
- 1. #TT_Telegram_sam11adel N/A
- 2. LeBron 81.9K posts
- 3. #DWTS 53.5K posts
- 4. #LakeShow 3,898 posts
- 5. Peggy 18.7K posts
- 6. Whitney 15.9K posts
- 7. Reaves 8,426 posts
- 8. Keyonte George 1,906 posts
- 9. Orioles 7,054 posts
- 10. Macklin Celebrini 2,546 posts
- 11. Jazz 27.1K posts
- 12. Grayson 7,024 posts
- 13. Taylor Ward 3,586 posts
- 14. #TheFutureIsTeal 1,560 posts
- 15. DUSD N/A
- 16. Tatum 16.5K posts
- 17. #Lakers 1,611 posts
- 18. Rantanen 2,089 posts
- 19. ELAINE 17.4K posts
- 20. Dylan 25.1K posts